
MEI Pharma (MEIP) P/E Ratio
P/E Ratio as of Jun 13, 2025: -0.48
Average-0.4600
Median-0.4600
Minimum-0.4900
Maximum-0.4400
-0.48
Past Month-0.03 (6.67%)
The P/E ratio for MEI Pharma (MEIP) is -0.48 as of Jun 13, 2025. This represents a decrease of -292.00% compared to its 12-month average P/E ratio of 0.25. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
MEI Pharma P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
MEI Pharma’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing MEI Pharma to industry peers.
MEI Pharma P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
MEI Pharma’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing MEI Pharma to industry peers.
MEI Pharma (MEIP) P/E Ratio Insights
See MEI Pharma’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in MEI Pharma (MEIP)
Order type
Buy in
Order amount
Est. shares
0 shares
MEI Pharma (MEIP) P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $2.2152 | -0.47 |
May 1, 2025 | $2.05 | -0.36 |
Apr 1, 2025 | $2.15 | -0.37 |
Mar 3, 2025 | $2.46 | -0.43 |
Feb 3, 2025 | $2.76 | -0.39 |
Jan 2, 2025 | $2.55 | -0.36 |
MEI Pharma (MEIP) End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -0.48 | +37.14% |
2024 | -0.35 | -137.23% |
2023 | 0.94 | -323.81% |
2022 | -0.42 | -86.79% |
2021 | -3.18 | -21.48% |
2020 | -4.05 | — |
FAQs About MEI Pharma (MEIP) P/E ratio
The latest P/E ratio of MEI Pharma (MEIP) is -0.48, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
MEI Pharma’s last 12-month average P/E ratio is 0.25, compared to its current P/E ratio of -0.48. This reflects a decrease of -292.00%.
MEI Pharma’s current P/E ratio of -0.48 is lower than its last 12-month average P/E of 0.25. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
MEI Pharma’s average P/E ratio over the last 3 years is 0.02. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
MEI Pharma’s average P/E ratio over the last 5 years is -1.36. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.